ZURICH, Oct 25 (Reuters) - Swiss medical devices maker Synthes (SYST.VX: Quote, Profile, Research) has been granted conditional approval from U.S. authorities for its ProDisc spinal disc replacement system for use in the neck area, or cervical spine.
Synthes said in a statement on Thursday that the U.S. Food and Drug Administration would issue full approval, allowing the product to go on the market, after it had reviewed ProDisc's manufacturing processes deemed them to be acceptable.
